Experimental Factor Ontology (EFO)
OWL
Last submission date April 15, 2025
ID http://purl.obolibrary.org/obo/CHEBI_49375
http://purl.obolibrary.org/obo/CHEBI_49375
https://agroportal.lirmm.fr/ontologies/EFO/CHEBI_49375
Loading
Preferred name

dasatinib (anhydrous)

Synonyms
N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide BMS Dasatinib BMS-354825 anh. dasatinib anhydrous dasatinib dasatinib dasatinib (anh.) dasatinibum N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE
See more
See less
Definitions
An aminopyrimidine that is 2-methylpyrimidine which is substituted at position 4 by the primary amino group of 2-amino-1,3-thiazole-5-carboxylic acid and at position 6 by a 4-(2-hydroxyethyl)piperazin-1-yl group, and in which the carboxylic acid group has been formally condensed with 2-chloro-6-methylaniline to afford the corresponding amide. A multi-targeted kinase inhibitor, it is used, particularly as the monohydrate, for the treatment of chronic, accelerated, or myeloid or lymphoid blast phase chronic myeloid leukemia. Note that the name 'dasatinib' is used to refer to the monohydrate (USAN) as well as to anhydrous dasatinib (INN).
Subject Author Type Created
No notes to display